These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30563296)

  • 1. Design and Properties of Ligand-Conjugated Guanine Oligonucleotides for Recovery of Mutated G-Quadruplexes.
    Takahashi S; Chelobanov B; Kim KT; Kim BH; Stetsenko D; Sugimoto N
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of the Formation and Function of Oxidized G-Quadruplexes by a Pyrene-Modified Guanine Tract.
    Takahashi S; Kim KT; Podbevšek P; Plavec J; Kim BH; Sugimoto N
    J Am Chem Soc; 2018 May; 140(17):5774-5783. PubMed ID: 29608858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents.
    Sun D; Guo K; Rusche JJ; Hurley LH
    Nucleic Acids Res; 2005; 33(18):6070-80. PubMed ID: 16239639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Modulation of DNA Replication along G-Quadruplex Based on Topology-Dependent Ligand Binding.
    Takahashi S; Kotar A; Tateishi-Karimata H; Bhowmik S; Wang ZF; Chang TC; Sato S; Takenaka S; Plavec J; Sugimoto N
    J Am Chem Soc; 2021 Oct; 143(40):16458-16469. PubMed ID: 34554731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Template-assembled synthetic G-quadruplex (TASQ): a useful system for investigating the interactions of ligands with constrained quadruplex topologies.
    Murat P; Bonnet R; Van der Heyden A; Spinelli N; Labbé P; Monchaud D; Teulade-Fichou MP; Dumy P; Defrancq E
    Chemistry; 2010 May; 16(20):6106-14. PubMed ID: 20397247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG Methylation Changes G-Quadruplex Structures Derived from Gene Promoters and Interaction with VEGF and SP1.
    Tsukakoshi K; Saito S; Yoshida W; Goto S; Ikebukuro K
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29670067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quadruplex-forming oligonucleotide targeted to the VEGF promoter inhibits growth of non-small cell lung cancer cells.
    Muench D; Rezzoug F; Thomas SD; Xiao J; Islam A; Miller DM; Sedoris KC
    PLoS One; 2019; 14(1):e0211046. PubMed ID: 30682194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into the binding of small ligand molecules to a G-quadruplex DNA located in the HIV-1 promoter.
    Mitrasinovic PM
    J Biomol Struct Dyn; 2018 Jul; 36(9):2292-2302. PubMed ID: 28728523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of G-quadruplex structure on vascular endothelial growth factor gene promoter depends on CpG methylation site and cation type.
    Yoshida W; Terasaka M; Laddachote S; Karube I
    Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1933-1937. PubMed ID: 29940278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 3'-end region of the human PDGFR-β core promoter nuclease hypersensitive element forms a mixture of two unique end-insertion G-quadruplexes.
    Onel B; Carver M; Agrawal P; Hurley LH; Yang D
    Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):846-854. PubMed ID: 29288770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanine-vacancy-bearing G-quadruplexes responsive to guanine derivatives.
    Li XM; Zheng KW; Zhang JY; Liu HH; He YD; Yuan BF; Hao YH; Tan Z
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14581-6. PubMed ID: 26553979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between G-Quadruplexes and Dnmt3a-Mediated Methylation of the
    Sergeev AV; Loiko AG; Genatullina AI; Petrov AS; Kubareva EA; Dolinnaya NG; Gromova ES
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in G-quadruplex sequence and topology differentially impacts human DNA polymerase fidelity.
    Stein M; Hile SE; Weissensteiner MH; Lee M; Zhang S; Kejnovský E; Kejnovská I; Makova KD; Eckert KA
    DNA Repair (Amst); 2022 Nov; 119():103402. PubMed ID: 36116264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.
    Membrino A; Cogoi S; Pedersen EB; Xodo LE
    PLoS One; 2011; 6(9):e24421. PubMed ID: 21931711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quadruplex-coupled kinetics distinguishes ligand binding between G4 DNA motifs.
    Halder K; Chowdhury S
    Biochemistry; 2007 Dec; 46(51):14762-70. PubMed ID: 18052204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulatory G4 motif of the Kirsten ras (KRAS) gene is sensitive to guanine oxidation: implications on transcription.
    Cogoi S; Ferino A; Miglietta G; Pedersen EB; Xodo LE
    Nucleic Acids Res; 2018 Jan; 46(2):661-676. PubMed ID: 29165690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel G-Quadruplexes Formed by Guanine-Rich Microsatellite Repeats Inhibit Human Topoisomerase I.
    Ogloblina AM; Bannikova VA; Khristich AN; Oretskaya TS; Yakubovskaya MG; Dolinnaya NG
    Biochemistry (Mosc); 2015 Aug; 80(8):1026-38. PubMed ID: 26547071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemical detection of Oxaliplatin induced DNA damage in G-quadruplex structures.
    Osmanoğulları SC; Forough M; Persil Çetinkol Ö; Arslan Udum Y; Toppare L
    Anal Biochem; 2023 Jun; 671():115149. PubMed ID: 37030427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-quadruplex-forming nucleic acids interact with splicing factor 3B subunit 2 and suppress innate immune gene expression.
    Matsumoto K; Okamoto K; Okabe S; Fujii R; Ueda K; Ohashi K; Seimiya H
    Genes Cells; 2021 Feb; 26(2):65-82. PubMed ID: 33290632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design.
    Harikrishna S; Kotaru S; Pradeepkumar PI
    Mol Biosyst; 2017 Jul; 13(8):1458-1468. PubMed ID: 28650023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.